Serum Gm allotype levels in common variable immunodeficiency: Preponderance of homozygous G2m(″,″) on IGHCG2

Experimental and Clinical Immunogenetics

Volumn 13, Issue 2, 1996, Pages 70-77

  Oxelius, Vivi Anne ^a   Ochs, Hans D ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Common variable immunodeficiency; Gm allotypes; IgG subclasses; IGHCG genes

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ALLELE; ALLOTYPE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CHILD; CHROMOSOME 14; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE LOCUS; GENE REARRANGEMENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNODIFFUSION; PRIORITY JOURNAL;

ADULT; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; GENE FREQUENCY; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN GM ALLOTYPES; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION;

EID: 0030453697     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Report of a WHO Scientific Group: Primary immunodeficiency diseases. Clin Exp Immunol 1995; 99(suppl 1):1-24.
2. Cunningham-Rundles C: Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33.
3. Hermaszewski RA, Webster ADB: Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. QJM 1993;86: 31-42.
4. Friedman JM, Fialkow PJ, Davis SD, Ochs HD, Wedgwood RJ: Autoimmunity in the relatives of patients with immunodeficiency diseases. Clin Exp Immunol 1977;28:375-388.
5. Wilton AN, Cobain TJ, Dawkins RL: Family studies of IgA deficiency. Immunogenetics 1985;21:333-342.
6. Howe HS, So AKL, Farrant J, Webster ADB: Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex. Clin Exp Immunol 1991: 83:387-390.
7. Volanakis JE, Zhu Z-B. Schaffer FM, Macon KJ, Palermos J, Barger BO, Go R, Campbell RD, Schroeder HW, Cooper MD: Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Ivest 1992;89:1914-1922.
8. Olerup O, Smith CIE, Björkander J, Hammarström L: Shared HLA class II associated genetic susceptibility and resistance, related to the HLA-DQB1 gene in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci USA 1992; 89:10653-10657.
9. Grubb RE: Human immunoglobulin allotypes and Mendelian polymorphism of the human immunoglobulin genes; in Oss CJ, Regenmortel MHV (eds): Immunochemistry. New York, Dekker, 1994, pp 47-68.
10. Oxelius V-A, Carlsson A-M, Hammarström L, Björkander J, Hanson L-A: Linkage of IgA deficiency to Gm allotypes: the influence of Gm allotypes on IgA-IgG subclass deficiency. Clin Exp Immunol 1995:99: 211-215.
11. Oxelius V-A: Suppressed G2m(n) levels from IGHCG2 in IgA deficiency. Exp Clin Immunogenet, in press.
12. Oxelius V-A: Lack of G2m(n) allotype in IgG subclass deficiency, in IgG2 deficiency together with lack of Glm(a) and G3m(g) and in IgG3 deficiency together with lack of G1m(f) and G3m(b). Scand J Immunol 1990;31:243-247.
13. Wedgwood RJ, Ochs HD, Oxelius V-A: IgG subclass levels in the serum of patients with primary immunodeficiency. Monogr Allergy. Basel, Karger, 1986, vol 20, pp 80-89.
14. Oxelius V-A: Serum IgG and IgG subclass contents in different Gm phenotypes. Scand J Immunol 1993: 37:149-153.
15. Oxelius V-A, Carlsson A-M: Quantitation of Gm allotypes. Scand J Immunol 1993;37:143-148.
16. Rautonen N. Seppälä I, Hallberg T, Grubb R, Mäkälä O: Determination of homozygosity and heterozygosity for the G2m(n) allotype by a monoclonal precipitating antibody. Exp Clin Immunogenet 1989;6:31-37.
17. Dray S: Effect of maternal iso-antibody on the quantitative expression of two allelic genes controlling the gamma-globulin allotypic specificities. Nature 1962;195:667-678.
18. Braun J, Berberian L, King L, Sanz I, Gowan HL: Restricted use of fetal VH3 immunoglobulin genes by unselected B cells in the adult. Predominance of 56p 1-like VH genes in common variable immunodeficiency. J Clin Invest 1992;89:1395-1402.
19. Saxon A, Sidell N, Zhang K: B cells from subjects with CVI can be driven to Ig production in response to CD 40 stimulation. Cell Immunol 1992;144:169-181.
20. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD: B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993;178:1097-1102.
21. Nonoyama S, Farrington M, Ishida H, Howard M, Ochs HD: Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J Clin Invest 1993;92:1282-1287.
22. Reinherz EL, Rubinstein A, Geha RS, Strelkausas AJ, Rosen FS, Schlossman SF: Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med 1979;301:1018-1021.
23. Sneller MC, Strober W: Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 1990,144:3762-3769.
24. Sneller MC, Strober W, Eisenstein E, Jaffe JS, Cunningham-Rundles C: New insights into common variable immunodeficiency. Ann Intern Med 1993;118:720-730.
25. Jaffe JS, Eisenstein E, Sneller MC, Strober W: T-cell abnormalities in common variable immunodeficiency. Pediatric Res 1993;33(suppl): 24-28.
26. Aukrust P, Muller F, Froland SS: Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol 1994;70: 217-224.
27. North ME, Webster ADB, Farrant J: Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C. Clin Exp Immunol 1991;85:198-201.
28. Eisenstein EM, Jaffe JS, Strober W: Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation. J Clin Invest 1993;13:247-258.
29. Farrington ML, Grosmaire LS, Nonoyama S, Fischer S, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD: CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 1994;91:1099-1103.
30. Pastorelli G, Roncarolo MG, Touraine JL, Peronne G, Tovo PA, De Vries JE: Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens, Clin Exp Immunol 1989;78:334-340.
31. Paganelli R, Capobianchi MR, Ensoli B, D'Offizi GP, Facchini J, Dianzani F, Aiuti F: Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic competence of lymphocytes. Clin Exp Immunol 1988;72:124-129.
32. Pandey JP, Fundenberg HH, Virella G, Kyong CU, Loadholt CB, Galbraith RM, Gotschlich EC, Parke JC: Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and meningococcus polysaccharides. Lancet 1979;i:190-192.
33. Granhoff DM, Suarez BK, Pandey JP. Shackleford PG: Genes associated with the Gm(23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J Infect Dis 1988;157:1142-1149.